Fluidigm Corp. (FLDM) Sees Unusually-High Trading Volume
Fluidigm Corp. (NASDAQ:FLDM) shares saw an uptick in trading volume on Wednesday . 902,531 shares changed hands during mid-day trading, an increase of 304% from the previous session’s volume of 223,503 shares.The stock last traded at $8.88 and had previously closed at $8.88.
A number of research firms recently issued reports on FLDM. Deutsche Bank AG began coverage on shares of Fluidigm Corp. in a research note on Wednesday, June 1st. They issued a “buy” rating on the stock. Cantor Fitzgerald reiterated a “buy” rating and issued a $13.00 target price on shares of Fluidigm Corp. in a research note on Thursday, June 2nd. Zacks Investment Research lowered shares of Fluidigm Corp. from a “hold” rating to a “sell” rating in a research note on Wednesday, May 11th. Finally, Mizuho decreased their price target on shares of Fluidigm Corp. from $11.00 to $8.00 and set a “buy” rating on the stock in a research report on Thursday, May 5th. Four analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $13.82.
The firm’s 50 day moving average is $9.64 and its 200 day moving average is $8.70. The firm’s market cap is $267.13 million.
Fluidigm Corp. (NASDAQ:FLDM) last announced its earnings results on Thursday, August 4th. The company reported ($0.64) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.58) by $0.06. During the same period last year, the firm earned ($0.53) EPS. The company had revenue of $28.20 million for the quarter, compared to analyst estimates of $29.62 million. The company’s revenue was down 1.5% compared to the same quarter last year. Equities research analysts anticipate that Fluidigm Corp. will post ($2.31) earnings per share for the current year.
A hedge fund recently bought a new stake in Fluidigm Corp. stock. Marshall Wace LLP purchased a new position in shares of Fluidigm Corp. (NASDAQ:FLDM) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 96,680 shares of the company’s stock, valued at approximately $1,045,000. Marshall Wace LLP owned approximately 0.34% of Fluidigm Corp. at the end of the most recent quarter.
Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.